Revenue from Mounjaro, the company’s Type 2 diabetes treatment, came in at $6.5 billion, above analysts’ consensus estimate ...
Eli Lilly beat Q3 estimates with $7.02 EPS and $17.60 billion revenue, raising full-year guidance as Zepbound and Mounjaro ...
Global Location Strategies (GLS), one of the world's leading corporate site selection firms, today unveiled its 2026 Best Places for Pharmaceutical Manufacturing Insights Report. The report identifies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback